Close Menu

NEW YORK – PerkinElmer kicked off the 39th Annual JP Morgan Healthcare Conference by providing an overview of 2020 with some projections for the year ahead and beyond.

Prior to its presentation, the firm announced that Q4 2020 revenues are expected to be about 66 percent above Q4 2019 levels on a reported basis and about 63 percent above the year-ago figure organically.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.